kabutan

Alfresa Holdings Corporation(2784) Summary

2784
TSE Prime
Alfresa Holdings Corporation
2,361.5
JPY
-29.5
(-1.23%)
Apr 30, 9:01 am JST
14.74
USD
Apr 29, 8:01 pm EDT
Result
PTS
outside of trading hours
2,366.7
Apr 30, 9:01 am JST
Summary Chart Historical News Financial Result
PER
11.9
PBR
0.86
Yield
2.88%
Margin Trading Ratio
0.65
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
2,377.5 JPY 14.84 USD
Previous Close Apr 28
2,391.0 JPY 15.01 USD
High Apr 30, 9:00 am
2,388.0 JPY 14.90 USD
Low Apr 30, 9:00 am
2,349.5 JPY 14.66 USD
Volume
21,600
Trading Value
0.05B JPY 0.32M USD
VWAP
2373.55 JPY 14.82 USD
Minimum Trading Value
236,150 JPY 1,474 USD
Market Cap
0.45T JPY 2.82B USD
Number of Trades
52
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
High
1-Year Average
1,134
1-Year High May 15, 2025
4,934
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 23,800 16,400 0.69
Apr 17, 2026 20,600 15,200 0.74
Apr 10, 2026 40,100 15,000 0.37
Apr 3, 2026 36,000 13,500 0.38
Mar 27, 2026 27,700 16,000 0.58
Company Profile
Alfresa Holdings Corporation is Japan's largest pharmaceutical wholesaler. The company was formed through the merger of Fukujin and Azwell. It also engages in pharmaceutical contract manufacturing and medical equipment sales.
Sector
Wholesale Trade
Alfresa Holdings Corporation operates in pharmaceutical wholesale, self-medication wholesale, pharmaceutical manufacturing, and healthcare-related businesses. In its core medical pharmaceutical wholesale business, the company operates nationwide, centered around Alfresa. The self-medication wholesale business handles over-the-counter drugs and health foods. In the pharmaceutical manufacturing business, Alfresa Pharma Corporation manufactures and sells pharmaceuticals and medical diagnostic reagents. The healthcare-related business operates a chain of dispensing pharmacies. As a holding company, Alfresa Holdings Corporation formulates group-wide management policies and business plans, aiming to effectively utilize management resources and continuously enhance corporate value.